Physician profile
Ellen Butts
NPI 1679065528
$5,679.37
in general payments reported to CMS, 2019-2025
15 companies · $1,047 in 2025
The $1,047 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $993 · 2021: $140 · 2022: $465 · 2023: $893 · 2024: $2,142 · 2025: $1,047.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,440 · Food and Beverage: $937 · Travel and Lodging: $517 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,440.00 |
| Food and Beverage | $936.67 |
| Travel and Lodging | $517.38 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $187.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $1,442.52 | 2024 | Xdemvy |
| Astellas Pharma Global Development | $990.00 | 2025 | Izervay |
| Novartis Pharmaceuticals Corporation | $822.57 | 2019-2022 | |
| Astellas Pharma US INC | $700.00 | 2023 | Izervay |
| Topcon Healthcare, INC. | $517.38 | 2024 | |
| Coopervision INC. | $313.33 | 2021-2024 | Synergeyes Contact Lens, Onefit Contact Lens, Myday Contact Lens |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $206.89 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $140.81 | 2022 | |
| Eyevance Pharmaceuticals LLC | $125.52 | 2019 | |
| Sight Sciences, INC. | $113.69 | 2019 | |
| Bausch & Lomb Americas INC. | $102.18 | 2022-2024 | Xiidra, Xipere |
| Allergan, INC. | $76.87 | 2019 | |
| Lkc Technologies, INC. | $57.00 | 2025 | |
| Sun Pharmaceutical Industries INC. | $44.00 | 2022 | |
| Thea Pharma INC. | $26.61 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Butts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.